Summary of findings: urate oxidase vs allopurinol
Incidence of clinical tumour lysis syndrome · children with haematological malignancy at risk of tumour lysis syndrome
Summary of findings: urate oxidase showed no clear difference in incidence of clinical tumour lysis syndrome ( compared with allopurinol (low certainty).
1 finding from 1 review
- Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer 2017 · Cochrane Headline outcomes onlyRR 0.77 [0.44, 1.33]1 study · 348 participantsLow